文献速递神经MR

酰胺质子转移加权成像直方图分析:对比增强区及瘤周区域胶质母细胞瘤与单发脑转移瘤的鉴别

Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.
PubMed 文献 · Eur Radiol · 2018-11-28

本研究纳入31例胶质母细胞瘤和17例单发脑转移瘤患者,比较增强区、瘤周高信号区及对侧正常白质的酰胺质子转移信号强度均值及直方图参数。结果显示增强区APTSI及直方图参数在胶质母细胞瘤与单发脑转移瘤间有显著差异,而瘤周区域无显著差异;结论认为增强区APTSI有助于鉴别两者,但血管源性水肿本身可升高APTSI,可能类似肿瘤浸润。

要点

  • 增强区APTSI均值胶质母细胞瘤2.92±0.74%高于单发脑转移瘤1.85±0.99%,直方图参数亦有显著差异。
  • 瘤周高信号区APTSI均值及直方图参数在胶质母细胞瘤与单发脑转移瘤间均无显著差异。
  • 血管源性水肿本身可显著升高APTSI,可能类似肿瘤浸润,判读瘤周APTSI时需谨慎。

核心结论

  • 增强区APTSI有助于鉴别胶质母细胞瘤与单发脑转移瘤,而瘤周区域APTSI无鉴别价值。

研究设计与样本

  • 研究纳入31例胶质母细胞瘤和17例单发脑转移瘤患者,基于增强T1加权与T2加权融合图像手动分割增强区及瘤周T2高信号区,比较APTSI均值及直方图参数。

关键影像表现/征象

  • 胶质母细胞瘤增强区APTSI均值2.92±0.74%最高,瘤周高信号区1.64±0.83%,对侧正常白质0.43±0.83%。
  • 单发脑转移瘤增强区APTSI均值1.85±0.99%与瘤周高信号区1.42±0.45%均高于对侧正常白质0.42±0.30%,增强区与瘤周高信号区间无显著差异。
  • 胶质母细胞瘤增强区APTSI均值及第10、25、50、75、90百分位数均显著高于单发脑转移瘤。

诊断标准与关键数值

  • 增强区APTSI均值:胶质母细胞瘤2.92±0.74% vs 单发脑转移瘤1.85±0.99%。
  • 瘤周高信号区APTSI均值:胶质母细胞瘤1.64±0.83% vs 单发脑转移瘤1.42±0.45%,无显著差异。
  • 对侧正常白质APTSI均值:胶质母细胞瘤0.43±0.83% vs 单发脑转移瘤0.42±0.30%。

临床应用与阅片要点

  • 增强区APTSI及直方图参数可用于辅助鉴别胶质母细胞瘤与单发脑转移瘤。
  • 瘤周高信号区APTSI在两者间无显著差异,判读时不应依赖瘤周APTSI进行鉴别。
  • 血管源性水肿本身可显著升高APTSI,可能类似肿瘤浸润,需注意此陷阱。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Differentiation of glioblastomas (GBMs) and solitary brain metastases (SBMs) is an important clinical problem. The aim of this study was to determine whether amide proton transfer-weighted (APTW) imaging is useful for distinguishing GBMs from SBMs.

METHODS: We examined 31 patients with GBM and 17 with SBM. For each tumor, enhancing areas (EAs) and surrounding non-enhancing areas with T2-prolongation (peritumoral high signal intensity areas, PHAs) were manually segmented using fusion images of the post-contrast T1-weighted and T2-weighted images. The mean amide proton transfer signal intensities (APTSIs) were compared among the EAs, PHAs, and contralateral normal appearing white matter (NAWM) within each tumor type. Furthermore, we analyzed APTSI histograms to compare the EAs and PHAs of GBMs and SBMs.

RESULTS: In GBMs, the mean APTSI in EAs (2.92 ± 0.74%) was the highest, followed by that in PHAs (1.64 ± 0.83%, p < 0.001) and NAWM (0.43 ± 0.83%, p < 0.001). In SBMs, the mean APTSI in EAs (1.85 ± 0.99%) and PHAs (1.42 ± 0.45%) were significantly higher than that in NAWM (0.42 ± 0.30%, p < 0.001), whereas no significant difference was found between EAs and PHAs. The mean and 10th, 25th, 50th, 75th, and 90th percentiles for APT in EAs of GBMs were significantly higher than those of SBMs. However, no significant difference was found between GBMs and SBMs in any histogram parameters for PHA.

CONCLUSIONS: APTSI in EAs, but not PHAs, is useful for differentiation between GBMs and SBMs.

KEY POINTS: • Amide proton transfer-weighted imaging and histogram analysis in the enhancing tumor can provide useful information for differentiation between glioblastomas and solitary brain metastasis. • Amide proton transfer signal intensity histogram parameters from peritumoral areas showed no significant difference between glioblastomas and solitary brain metastasis. • Vasogenic edema alone can substantially increase amide proton transfer signal intensity which may mimic tumor invasion.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kamimura K, Nakajo M, Yoneyama T, et al. Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions. Eur Radiol. 2018. PMID: 30488111. doi:10.1007/s00330-018-5832-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。